The authors conclude that if the goal of screening is to reduce the risk for death, then the evidence
supporting flexible sigmoidoscopy is substantially stronger than that of other screening methods.
Challenges highlighted for the year ahead were: Moving forward on piloting
flexible sigmoidoscopy bowel screening; a national awareness campaign on bowel cancer; improving diagnostic capacity and productivity; the needs of survivors in different post-treatment phases; providing information to commissioners and providers about patients» experience of care; giving
support to tackle issues such as information provision and better communication.